Novo Nordisk added ziltivekimab to its pipeline in connection with the acquisition of Corvidia Therapeutics for USD 725 million in 2020 with the potential for the price to rise to USD 2.1 billion
Proper timing of medications and regular thyroid monitoring are important to ensure both conditions remain well-controlled
However, ongoing monitoring depends on patient-initiated check-ins rather than mandatory follow-up labs
Your labs, health goals, and expectations will be reviewed during this session, and a personalized plan will be created
If your tirzepatide nausea isnt improving, its wise to let your healthcare provider know
Still, she continued to feel too nauseous, so she decided by herself to start skipping every other dose